GleamWall
中文EN

HR Healthcare Realty Trust Inc

Real Estate Investment Trusts · NYSE · SEC CIK 1360604 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-5.8%
TTM net income YoY87.8%
TTM EPS YoY86.9%
Revenue 3-yr CAGR-5.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin-4.0%
FCF margin—
EBITDA margin—

Returns

ROE-1.0%
ROA-0.5%
ROIC (approx.)—
Asset turnover0.12x

Leverage & solvency

Liabilities / assets53.9%
Debt / equity1.04x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income-10.01x
Accruals ratio-5.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$286.64M$281.85M$278.99M$286.30M$297.76M$297.50M$298.98M$309.77M
SG&A expense$12.44M$14.36M$17.34M$13.79M$21.77M$23.48M$13.53M$34.21M
Interest expense$44.85M$45.15M$43.89M$48.19M$52.64M$53.35M$54.81M$58.27M
Net income-$15.76M-$43.51M-$56,000$14.39M-$57.74M-$157.85M-$44.87M-$106.85M
EPS (basic)-0.05-0.130.00—-0.17-0.45-0.13—
EPS (diluted)-0.05-0.130.00—-0.17-0.45-0.13—
Dividends declared per share0.240.240.240.240.240.310.310.31
Weighted avg. shares (diluted)340.62M342.30M347.44M—349.96M349.63M349.54M—
Banking
Loans, net$6.02M$6.00M$122.35M$123.25M$123.35M$124.13M$123.81M$123.67M
Balance sheet
Cash & equivalents$17.50M$18.99M$26.23M$26.17M$43.34M$25.51M$25.72M$68.92M
Goodwill———————$0
Total assets$8.96B$9.00B$9.15B$9.21B$9.86B$10.24B$10.50B$10.65B
Long-term debt$4.25B$4.17B$4.10B$3.91B$4.49B$4.69B$4.73B$4.66B
Total debt$4.25B$4.17B$4.10B$3.91B$4.49B$4.69B$4.73B$4.66B
Total liabilities$4.83B$4.73B$4.65B$4.53B$5.11B$5.35B$5.35B$5.35B
Shareholders' equity$4.08B$4.22B$4.44B$4.62B$4.68B$4.82B$5.08B$5.23B
Net debt$4.23B$4.15B$4.08B$3.89B$4.44B$4.67B$4.71B$4.59B
Shares outstanding340.00M342.72M346.53M351.60M351.60M351.57M351.00M350.53M
Cash flow statement
Operating cash flow$122.29M$142.19M$52.88M$132.34M$113.75M$163.22M$47.79M$138.01M
Investing cash flow-$61.41M-$7.02M-$45.31M$526.48M$226.28M-$3.10M-$38.83M$418.77M
Financing cash flow-$62.36M-$142.41M-$7.50M-$676.15M-$322.19M-$160.18M-$52.15M-$514.03M
Depreciation & amortization$128.10M$128.06M$128.99M$127.41M$143.64M$153.48M$150.97M$160.33M
Stock-based compensation$4.56M$4.42M$5.42M$3.35M$7.23M$8.77M$3.03M$16.97M
Dividends paid$82.25M$82.25M$83.90M$84.39M$84.77M$108.95M$108.81M$109.79M
Share buybacks$43,000$731,000$2.04M$379,000$2.92M$498,000$215,000$8.56M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.